GSA Capital Partners LLP bought a new stake in Constellium SE (NYSE:CSTM – Free Report) in the third quarter, HoldingsChannel reports. The institutional investor bought 42,079 shares of the industrial products company’s stock, valued at approximately $684,000.
Several other institutional investors also recently made changes to their positions in CSTM. Westwood Holdings Group Inc. lifted its stake in shares of Constellium by 12,970.1% in the first quarter. Westwood Holdings Group Inc. now owns 2,796,868 shares of the industrial products company’s stock valued at $61,839,000 after purchasing an additional 2,775,469 shares during the period. Kailix Advisors LLC increased its holdings in Constellium by 40.0% in the second quarter. Kailix Advisors LLC now owns 1,446,645 shares of the industrial products company’s stock valued at $29,222,000 after buying an additional 413,605 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Constellium by 35.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,395,607 shares of the industrial products company’s stock worth $22,693,000 after acquiring an additional 364,423 shares in the last quarter. Millennium Management LLC grew its holdings in shares of Constellium by 29.9% in the 2nd quarter. Millennium Management LLC now owns 1,173,840 shares of the industrial products company’s stock worth $22,127,000 after acquiring an additional 270,475 shares during the period. Finally, Vaughan Nelson Investment Management L.P. increased its stake in Constellium by 8.3% in the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 3,360,198 shares of the industrial products company’s stock valued at $63,339,000 after purchasing an additional 257,618 shares in the last quarter. 92.59% of the stock is currently owned by hedge funds and other institutional investors.
Constellium Price Performance
NYSE:CSTM opened at $11.46 on Monday. Constellium SE has a 12-month low of $10.49 and a 12-month high of $23.20. The firm has a market cap of $1.65 billion, a price-to-earnings ratio of 15.49 and a beta of 1.65. The company’s 50-day moving average is $14.16 and its two-hundred day moving average is $17.11. The company has a current ratio of 1.28, a quick ratio of 0.52 and a debt-to-equity ratio of 1.93.
Analyst Ratings Changes
A number of analysts have commented on the company. Deutsche Bank Aktiengesellschaft downgraded Constellium from a “buy” rating to a “hold” rating and decreased their target price for the stock from $22.00 to $12.00 in a research report on Thursday, October 24th. JPMorgan Chase & Co. lowered their price objective on shares of Constellium from $25.00 to $24.00 and set an “overweight” rating on the stock in a research note on Friday, October 11th. StockNews.com cut shares of Constellium from a “buy” rating to a “hold” rating in a research report on Thursday, October 24th. Finally, BMO Capital Markets lowered their price target on shares of Constellium from $22.00 to $18.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $21.00.
Get Our Latest Stock Report on Constellium
About Constellium
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Featured Articles
- Five stocks we like better than Constellium
- Short Selling: How to Short a Stock
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Why Are Stock Sectors Important to Successful Investing?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding CSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Constellium SE (NYSE:CSTM – Free Report).
Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.